dsm‑firmenich’s new strategic partnership with Italy‑based start‑up Nous marks a significant moment for the global functional ingredients market, bringing the novel botanical ingredient Koncentra into commercial focus.

Designed to support energy, focus and mood, Koncentra is a more balanced, caffeine‑free performance solution — a direction increasingly favoured by consumers seeking sustained vitality without overstimulation.

The collaboration builds on dsm‑firmenich’s earlier investment in Nous and now expands into a full development and commercialisation alliance, accelerating the ingredient’s path from clinical validation to market‑ready applications.

Koncentra is the result of an extensive botanical screening process and a proprietary extraction technology that preserves the integrity of its natural bioactive compounds. This approach delivers a new formulation philosophy for the energy category: one that avoids the jitters, anxiety and crashes commonly associated with caffeine while offering multi‑functional support across physical and cognitive performance.

As consumer concern around daily energy levels continues to rise — with around 68% of people globally reporting they worry about their energy throughout the day — the demand for alternatives to stimulant‑based solutions is intensifying.

Functional beverages remain the most active innovation space, with energy‑related claims dominating the category. Koncentra enters this landscape as a timely, science‑backed option for brands looking to differentiate.

The ingredient’s formulation advantages further strengthen its commercial potential. Koncentra offers excellent solubility, a low effective dose and minimal impact on taste, colour or turbidity, making it suitable for a wide range of food and beverage applications. Its versatility allows manufacturers to explore next‑generation concepts across functional drinks, nootropic beverages, better‑for‑you sodas and mood‑supporting formats. This positions Koncentra as a practical solution for developers seeking clean‑label, botanical‑based performance ingredients that integrate seamlessly into existing product architectures.

Through the partnership, dsm‑firmenich will support the design of clinical trials to substantiate Koncentra’s claims across energy, cognitive function and physical performance. The company will also strengthen regulatory positioning and claims development, leveraging its global expertise in consumer insights, application science and compliance frameworks. This combination of Nous’s ingredient innovation and dsm‑firmenich’s market infrastructure aims to accelerate Koncentra’s transition from promising botanical to fully validated, commercially scalable solution.

Both companies see the collaboration as an opportunity to redefine the energy category. Ingrid Damen, director of global business development for beverages at dsm‑firmenich, highlights the growing demand for science‑backed energy solutions that move beyond caffeine, while Nous founder Lorenzo Pessini emphasises the need for balanced performance ingredients that support sustained energy, focus and mood without overstimulation. Together, they aim to reshape how brands approach energy formulation, offering consumers a more holistic alternative that aligns with evolving expectations around wellbeing and natural functionality.

As the functional food and drink market continues to expand, Koncentra’s arrival — backed by dsm‑firmenich’s validation and global reach — sets a new benchmark for botanical performance ingredients. It signals a broader industry shift toward caffeine‑free innovation, multi‑benefit formulations and natural approaches to cognitive and mood support. For manufacturers, the partnership opens the door to a new generation of functional products designed to meet modern consumer needs with greater efficacy, balance and scientific credibility.